THE LEUKEMIA & LYMPHOMA SOCIETYINC
THE LEUKEMIA & LYMPHOMA SOCIETYINC
THE LEUKEMIA & LYMPHOMA SOCIETYINC
Income Statement
Fiscal Year Start:
Jul 1
Revenues in 2024
$368,242,059
Contributions
55%
Fundraising Events
37%
Program Services
4%
Investments
4%
Other
<1%
Government Grants
0%
Membership Dues
0%
Expenses in 2024
$371,792,172
Salaries & Benefits
37%
Grants
32%
Other
10%
Offices, Occupancy & IT
9%
Fees to Service Providers
8%
Advertising & Promotion
2%
Depreciation
1%
Benefits to Members
0%
Interest
0%
Revenues
2023
2024
Change
Contributions
$212,846,554
$203,922,511
-4%
Government Grants
$0
$0
-
Fundraising Events
$144,824,080
$134,689,222
-7%
Program Services
$9,531,279
$14,932,514
+57%
Membership Dues
$0
$0
-
Investments
$11,201,769
$14,243,283
+27%
Other
-$65,192
$454,529
-797%
Total Revenues
$378,338,490
$368,242,059
-3%
Expenses
2023
2024
Change
Grants
$147,771,106
$119,474,064
-19%
Benefits to Members
$0
$0
-
Salaries & Benefits
$119,899,883
$137,851,341
+15%
Fees to Service Providers
$43,127,968
$30,017,340
-30%
Advertising & Promotion
$9,534,205
$8,557,338
-10%
Offices, Occupancy & IT
$33,205,321
$31,962,065
-4%
Interest
$0
$0
-
Depreciation
$4,699,950
$5,425,197
+15%
Other
$27,834,535
$38,504,827
+38%
Total Expenses
$386,072,968
$371,792,172
-4%
Net income
2023
2024
Change
Net income
-$7,734,478
-$3,550,113
+54%
Functional Expenses
Summary
2023
2024
Change
Program
$277,116,716
$277,319,136
+0%
Admin
$58,376,298
$50,274,278
-14%
Fundraising
$50,579,954
$44,198,758
-13%
Total Expenses
$386,072,968
$371,792,172
-4%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)